3-Iodobenzylguanidine
The therapeutic efficacy of Iobenguane can be decreased when used in combination with Nortriptyline.
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Nortriptyline.
Abiraterone
The serum concentration of Nortriptyline can be increased when it is combined with Abiraterone.
Advertisement
Acenocoumarol
Nortriptyline may increase the anticoagulant activities of Acenocoumarol.
Acepromazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Aceprometazine.
Advertisement
Acetophenazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Acetophenazine.
Albuterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.
Alfaxalone
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Alfaxalone.
Advertisement
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Nortriptyline.
Almotriptan
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Almotriptan.
Alogliptin
The serum concentration of Nortriptyline can be increased when it is combined with Alogliptin.
alpha 1-Antitrypsin
The serum concentration of Nortriptyline can be increased when it is combined with Alpha-1-proteinase inhibitor.
Alpha 1-Proteinase Inhibitor, Human
The serum concentration of Nortriptyline can be increased when it is combined with Alpha-1-proteinase inhibitor.
Alphaprodine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Nortriptyline.
Altretamine
Altretamine may increase the orthostatic hypotensive activities of Nortriptyline.
Amiodarone
The metabolism of Nortriptyline can be decreased when combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Nortriptyline.
Amobarbital
The metabolism of Nortriptyline can be increased when combined with Amobarbital.
Amoxapine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Amoxapine.
Amphetamine
Nortriptyline may increase the stimulatory activities of Amphetamine.
Amprenavir
The serum concentration of Nortriptyline can be increased when it is combined with Amprenavir.
Anagrelide
Nortriptyline may increase the QTc-prolonging activities of Anagrelide.
Antithrombin III
The serum concentration of Nortriptyline can be increased when it is combined with Antithrombin III human.
Antithrombin III, Human
The serum concentration of Nortriptyline can be increased when it is combined with Antithrombin III human.
Apalutamide
The serum concentration of Nortriptyline can be decreased when it is combined with Apalutamide.
Apixaban
The serum concentration of Nortriptyline can be increased when it is combined with Apixaban.
Apomorphine
Nortriptyline may decrease the antihypertensive activities of Apomorphine.
Apraclonidine
Nortriptyline may decrease the antihypertensive activities of Apraclonidine.
Aprepitant
The serum concentration of Nortriptyline can be increased when it is combined with Aprepitant.
Aprotinin
The serum concentration of Nortriptyline can be increased when it is combined with Aprotinin.
Arbutamine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Arbutamine.
Arformoterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Arformoterol.
Argatroban
The serum concentration of Nortriptyline can be increased when it is combined with Argatroban.
Argatroban Anhydrous
The serum concentration of Nortriptyline can be increased when it is combined with Argatroban.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Nortriptyline.
Armodafinil
The metabolism of Nortriptyline can be decreased when combined with Armodafinil.
Arsenic Trioxide
Nortriptyline may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
Nortriptyline may increase the QTc-prolonging activities of Artemether.
Articaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Articaine.
Asenapine
Nortriptyline may increase the QTc-prolonging activities of Asenapine.
Asunaprevir
The serum concentration of Nortriptyline can be increased when it is combined with Asunaprevir.
Atazanavir
The metabolism of Nortriptyline can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Nortriptyline can be decreased when combined with Atomoxetine.
Azelastine
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azithromycin
The metabolism of Nortriptyline can be decreased when combined with Azithromycin.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Nortriptyline.
Bambuterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Bambuterol.
Barbexaclone
The metabolism of Nortriptyline can be increased when combined with Barbexaclone.
Barbital
The metabolism of Nortriptyline can be increased when combined with Barbital.
Bedaquiline
Nortriptyline may increase the QTc-prolonging activities of Bedaquiline.
Benazepril
The serum concentration of Nortriptyline can be increased when it is combined with Benazepril.
Benoxinate
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Benzocaine.
Benzphetamine
Nortriptyline may decrease the antihypertensive activities of Benzphetamine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Benzyl alcohol.
Betaxolol
The metabolism of Nortriptyline can be decreased when combined with Betaxolol.
Bethanidine
Nortriptyline may decrease the antihypertensive activities of Bethanidine.
Bivalirudin
The serum concentration of Nortriptyline can be increased when it is combined with Bivalirudin.
Boceprevir
The metabolism of Nortriptyline can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Nortriptyline can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Nortriptyline can be decreased when it is combined with Bosentan.
Brexpiprazole
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Nortriptyline.
Bromocriptine
Nortriptyline may decrease the antihypertensive activities of Bromocriptine.
Bromperidol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Bupivacaine.
Buprenorphine
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Bupropion
The metabolism of Nortriptyline can be decreased when combined with Bupropion.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Nortriptyline.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Nortriptyline.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Nortriptyline.
Butamben
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Nortriptyline.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Nortriptyline.
Caffeine
The metabolism of Nortriptyline can be decreased when combined with Caffeine.
Capecitabine
The metabolism of Nortriptyline can be decreased when combined with Capecitabine.
Captopril
The serum concentration of Nortriptyline can be increased when it is combined with Captopril.
Carbamazepine
The metabolism of Nortriptyline can be increased when combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Carbinoxamine.
Cariprazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Cariprazine.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Nortriptyline.
Celecoxib
The metabolism of Nortriptyline can be decreased when combined with Celecoxib.
Celiprolol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Celiprolol.
Ceritinib
The serum concentration of Nortriptyline can be increased when it is combined with Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Nortriptyline.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Chloral hydrate.
Chloramphenicol
The metabolism of Nortriptyline can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Nortriptyline.
Chlormethiazole
The risk or severity of adverse effects can be increased when Nortriptyline is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Chloroprocaine.
Chloroquine
The metabolism of Nortriptyline can be decreased when combined with Chloroquine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Chlorphenamine.
Chlorpromazine
The metabolism of Nortriptyline can be decreased when combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Nortriptyline.
Cholecalciferol
The metabolism of Nortriptyline can be decreased when combined with Cholecalciferol.
Cholesterol
The serum concentration of Nortriptyline can be increased when it is combined with Cholesterol.
Cilastatin
The serum concentration of Nortriptyline can be increased when it is combined with Cilastatin.
Cilazapril
The serum concentration of Nortriptyline can be increased when it is combined with Cilazapril.
Cimetidine
The metabolism of Nortriptyline can be decreased when combined with Cimetidine.
Cinacalcet
The serum concentration of Nortriptyline can be increased when it is combined with Cinacalcet.
Ciprofloxacin
Nortriptyline may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Nortriptyline may increase the QTc-prolonging activities of Cisapride.
Citalopram
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Citalopram.
Clarithromycin
The metabolism of Nortriptyline can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Nortriptyline can be decreased when combined with Clemastine.
Clenbuterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Clenbuterol.
Clidinium
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Clidinium.
Clobazam
The metabolism of Nortriptyline can be decreased when combined with Clobazam.
Clomipramine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Clonazepam.
Clonidine
Nortriptyline may decrease the antihypertensive activities of Clonidine.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Nortriptyline.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Nortriptyline.
Clotrimazole
The metabolism of Nortriptyline can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Nortriptyline can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Nortriptyline can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Nortriptyline can be decreased when combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Nortriptyline.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Nortriptyline.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Nortriptyline.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Nortriptyline.
Crisaborole
The metabolism of Nortriptyline can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Nortriptyline can be decreased when combined with Crizotinib.
Cyamemazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Cyamemazine.
Cyclizine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Cyclobenzaprine.
Cyclosporine
The metabolism of Nortriptyline can be decreased when combined with Cyclosporine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Nortriptyline.
Cyproterone Acetate
The serum concentration of Nortriptyline can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
The serum concentration of Nortriptyline can be increased when it is combined with Dabigatran etexilate.
Dabrafenib
The serum concentration of Nortriptyline can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Dapiprazole.
Darifenacin
The metabolism of Nortriptyline can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Nortriptyline can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Nortriptyline can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Nortriptyline can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Nortriptyline can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Nortriptyline can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Nortriptyline.
Desipramine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Desloratadine.
Desmopressin
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Desmopressin.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Nortriptyline.
Dexmedetomidine
Nortriptyline may decrease the antihypertensive activities of Dexmedetomidine.
Dexmethylphenidate
The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Nortriptyline.
Dextroamphetamine
Nortriptyline may increase the stimulatory activities of Dextroamphetamine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Nortriptyline.
Dextromoramide
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Nortriptyline.
Dibucaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Cinchocaine.
Dicumarol
Nortriptyline may increase the anticoagulant activities of Dicoumarol.
Diethylpropion
Nortriptyline may increase the stimulatory activities of Diethylpropion.
Difenoxin
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Nortriptyline.
Dihydroergotamine
Nortriptyline may decrease the antihypertensive activities of Dihydroergotamine.
Diltiazem
The metabolism of Nortriptyline can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Dimenhydrinate.
Diphenhydramine
The metabolism of Nortriptyline can be decreased when combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Nortriptyline.
Dipivefrin
Nortriptyline may decrease the antihypertensive activities of Dipivefrin.
Disopyramide
Nortriptyline may increase the QTc-prolonging activities of Disopyramide.
Dobutamine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Dobutamine.
Dofetilide
Nortriptyline may increase the QTc-prolonging activities of Dofetilide.
Dolasetron
Nortriptyline may increase the QTc-prolonging activities of Dolasetron.
Domperidone
Nortriptyline may increase the QTc-prolonging activities of Domperidone.
Dothiepin
The metabolism of Nortriptyline can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Doxepin.
Doxycycline
The metabolism of Nortriptyline can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Nortriptyline can be decreased when combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Dronedarone
Nortriptyline may increase the QTc-prolonging activities of Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Droxidopa
Nortriptyline may decrease the antihypertensive activities of Droxidopa.
Duloxetine
Duloxetine may increase the serotonergic activities of Nortriptyline.
Dyclonine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Dyclonine.
Edoxaban
The serum concentration of Nortriptyline can be increased when it is combined with Edoxaban.
Efavirenz
The metabolism of Nortriptyline can be decreased when combined with Efavirenz.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Nortriptyline.
Eliglustat
Nortriptyline may increase the QTc-prolonging activities of Eliglustat.
Enalapril
The serum concentration of Nortriptyline can be increased when it is combined with Enalapril.
Enalaprilat
The serum concentration of Nortriptyline can be increased when it is combined with Enalaprilat.
Enalaprilat Anhydrous
The serum concentration of Nortriptyline can be increased when it is combined with Enalaprilat.
Enflurane
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Nortriptyline.
Enzalutamide
The serum concentration of Nortriptyline can be decreased when it is combined with Enzalutamide.
Epigallocatechin Gallate
The serum concentration of Nortriptyline can be increased when it is combined with Epigallocatechin Gallate.
Epinephrine
Nortriptyline may decrease the antihypertensive activities of Epinephrine.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ergoloid mesylate.
Ergonovine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ergonovine.
Ergotamine
Nortriptyline may decrease the antihypertensive activities of Ergotamine.
Erythromycin
The metabolism of Nortriptyline can be decreased when combined with Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Escitalopram.
Eslicarbazepine Acetate
The metabolism of Nortriptyline can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Nortriptyline can be decreased when combined with Esomeprazole.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Nortriptyline.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Nortriptyline.
Ethanol
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Etifoxine.
Etomidate
Nortriptyline may decrease the antihypertensive activities of Etomidate.
Etravirine
The metabolism of Nortriptyline can be decreased when combined with Etravirine.
Ezogabine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Felbamate.
Fenoterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Fenoterol.
Fentanyl
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Fentanyl.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Nortriptyline.
Fexofenadine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Fexofenadine.
Fibrinolysis Inhibitor
The serum concentration of Nortriptyline can be increased when it is combined with Aprotinin.
Flecainide
Nortriptyline may increase the QTc-prolonging activities of Flecainide.
Flibanserin
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Flibanserin.
Floxuridine
The metabolism of Nortriptyline can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Nortriptyline can be decreased when combined with Fluconazole.
Fluindione
Nortriptyline may increase the anticoagulant activities of Fluindione.
Flunarizine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Flunitrazepam.
Fluorouracil
The metabolism of Nortriptyline can be decreased when combined with Fluorouracil.
Fluoxetine
The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.
Flupenthixol
Nortriptyline may increase the QTc-prolonging activities of Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nortriptyline.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Nortriptyline.
Fluspirilene
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Fluticasone propionate.
Fluvastatin
The metabolism of Nortriptyline can be decreased when combined with Fluvastatin.
Fluvoxamine
The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.
Formoterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Formoterol.
Fosamprenavir
The serum concentration of Nortriptyline can be increased when it is combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Nortriptyline can be increased when it is combined with Fosaprepitant.
Fosinopril
The serum concentration of Nortriptyline can be increased when it is combined with Fosinopril.
Fosphenytoin
The metabolism of Nortriptyline can be increased when combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Fospropofol.
Frovatriptan
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Frovatriptan.
Furazolidone
Furazolidone may increase the serotonergic activities of Nortriptyline.
Fusidate
The serum concentration of Nortriptyline can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Nortriptyline can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Nortriptyline.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Gabapentin Enacarbil.
Gadobenate
Nortriptyline may increase the QTc-prolonging activities of Gadobenic acid.
Gemfibrozil
The metabolism of Nortriptyline can be decreased when combined with Gemfibrozil.
Gemifloxacin
Nortriptyline may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Nortriptyline may increase the QTc-prolonging activities of Gemifloxacin.
Glutethimide
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Glutethimide.
Goserelin
Nortriptyline may increase the QTc-prolonging activities of Goserelin.
Granisetron
Nortriptyline may increase the QTc-prolonging activities of Granisetron.
Guanabenz
Nortriptyline may decrease the antihypertensive activities of Guanabenz.
Guanfacine
Nortriptyline may decrease the antihypertensive activities of Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Halazepam.
Haloperidol
The metabolism of Nortriptyline can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Heroin.
Hexobarbital
The metabolism of Nortriptyline can be increased when combined with Hexobarbital.
Hydrocodone
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Nortriptyline.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Hypoxis hemerocallidea root extract
The metabolism of Nortriptyline can be increased when combined with St. John's Wort.
Ibutilide
Nortriptyline may increase the QTc-prolonging activities of Ibutilide.
Idelalisib
The metabolism of Nortriptyline can be decreased when combined with Idelalisib.
Iloperidone
Nortriptyline may increase the QTc-prolonging activities of Iloperidone.
Imatinib
The metabolism of Nortriptyline can be decreased when combined with Imatinib.
Imidapril
The serum concentration of Nortriptyline can be increased when it is combined with Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Nortriptyline.
Indacaterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Indacaterol.
Indinavir
The metabolism of Nortriptyline can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Nortriptyline can be decreased when combined with Indinavir.
Iproniazid
Iproniazid may increase the serotonergic activities of Nortriptyline.
Irbesartan
The metabolism of Nortriptyline can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Nortriptyline can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Nortriptyline can be decreased when combined with Isavuconazonium.
Isocarboxazid
The therapeutic efficacy of Nortriptyline can be increased when used in combination with Isocarboxazid.
Isoetharine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Nortriptyline.
Isoflurophate
The serum concentration of Nortriptyline can be increased when it is combined with Isoflurophate.
Isoniazid
The metabolism of Nortriptyline can be decreased when combined with Isoniazid.
Isoproterenol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Isoprenaline.
Isradipine
The metabolism of Nortriptyline can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Nortriptyline can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Nortriptyline can be increased when it is combined with Ivacaftor.
Ixazomib
The serum concentration of Nortriptyline can be increased when it is combined with Ixazomib.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Nortriptyline.
Ketazolam
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ketazolam.
Ketoconazole
The metabolism of Nortriptyline can be decreased when combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Lamotrigine.
Leflunomide
The metabolism of Nortriptyline can be decreased when combined with Leflunomide.
Lenvatinib
Nortriptyline may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Nortriptyline may increase the QTc-prolonging activities of Lenvatinib.
Lepirudin
The serum concentration of Nortriptyline can be increased when it is combined with Lepirudin.
Leuprolide
Nortriptyline may increase the QTc-prolonging activities of Leuprolide.
Levalbuterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levosalbutamol.
Levetiracetam
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levodopa.
Levofloxacin
Nortriptyline may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Nortriptyline may increase the QTc-prolonging activities of Levofloxacin.
Levomethadyl
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levomilnacipran.
Levonordefrin
Nortriptyline may decrease the antihypertensive activities of Levonordefrin.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Nortriptyline.
Levothyroxine
Levothyroxine may increase the arrhythmogenic activities of Nortriptyline.
Lidocaine
The metabolism of Nortriptyline can be decreased when combined with Lidocaine.
Linagliptin
The serum concentration of Nortriptyline can be increased when it is combined with Linagliptin.
Linezolid
Linezolid may increase the serotonergic activities of Nortriptyline.
Liothyronine
Liothyronine may increase the arrhythmogenic activities of Nortriptyline.
Lisdexamfetamine
Nortriptyline may increase the stimulatory activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Nortriptyline may increase the stimulatory activities of Lisdexamfetamine.
Lisinopril
The serum concentration of Nortriptyline can be increased when it is combined with Lisinopril.
Lisinopril Anhydrous
The serum concentration of Nortriptyline can be increased when it is combined with Lisinopril.
Lithium
Lithium may increase the neurotoxic activities of Nortriptyline.
Lithium Cation
Lithium may increase the neurotoxic activities of Nortriptyline.
Lofexidine
Nortriptyline may decrease the antihypertensive activities of Lofexidine.
Lopinavir
The metabolism of Nortriptyline can be decreased when combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Nortriptyline.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Nortriptyline.
Lorcaserin
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Lorcaserin.
Lormetazepam
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Lormetazepam.
Losartan
The metabolism of Nortriptyline can be decreased when combined with Losartan.
Lovastatin
The metabolism of Nortriptyline can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Nortriptyline.
Luliconazole
The serum concentration of Nortriptyline can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Nortriptyline can be decreased when it is combined with Lumacaftor.
Lumefantrine
Nortriptyline may increase the QTc-prolonging activities of Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Nortriptyline.
Magnesium Sulfate
The therapeutic efficacy of Nortriptyline can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Nortriptyline can be increased when used in combination with Magnesium sulfate.
Manidipine
The metabolism of Nortriptyline can be decreased when combined with Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Nortriptyline.
Mephentermine
Nortriptyline may increase the vasopressor activities of Mephentermine.
Mephobarbital
The metabolism of Nortriptyline can be increased when combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Nortriptyline.
Mesoridazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Mesoridazine.
Metaproterenol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Orciprenaline.
Metaraminol
Nortriptyline may increase the vasopressor activities of Metaraminol.
Metaxalone
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Metaxalone.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Nortriptyline.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Methadyl Acetate.
Methamphetamine
Nortriptyline may decrease the antihypertensive activities of Methamphetamine.
Methapyrilene
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Nortriptyline.
Methohexital
The metabolism of Nortriptyline can be increased when combined with Methohexital.
Methotrimeprazine
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxamine
Nortriptyline may increase the vasopressor activities of Methoxamine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Methsuximide.
Methylene blue
Nortriptyline may increase the serotonergic activities of Methylene blue.
Methylphenidate
The risk or severity of adverse effects can be increased when Methylphenidate is combined with Nortriptyline.
Metoclopramide
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Nortriptyline.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Nortriptyline.
Metylperon
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Melperone.
Metyrosine
The risk or severity of adverse effects can be increased when Metyrosine is combined with Nortriptyline.
Mexiletine
The metabolism of Nortriptyline can be decreased when combined with Mexiletine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Nortriptyline.
Midodrine
Nortriptyline may increase the vasopressor activities of Midodrine.
Midostaurin
The metabolism of Nortriptyline can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Nortriptyline can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Milnacipran.
Minaprine
Minaprine may increase the serotonergic activities of Nortriptyline.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Mirabegron
The metabolism of Nortriptyline can be decreased when combined with Mirabegron.
Mirtazapine
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Mitotane
The serum concentration of Nortriptyline can be decreased when it is combined with Mitotane.
Moclobemide
Moclobemide may increase the serotonergic activities of Nortriptyline.
Modafinil
The metabolism of Nortriptyline can be decreased when combined with Modafinil.
Moexipril
The serum concentration of Nortriptyline can be increased when it is combined with Moexipril.
Molindone
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Nortriptyline.
Moxifloxacin
Nortriptyline may increase the QTc-prolonging activities of Moxifloxacin.
Moxonidine
The therapeutic efficacy of Moxonidine can be decreased when used in combination with Nortriptyline.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Nortriptyline.
Naphazoline
Nortriptyline may decrease the antihypertensive activities of Naphazoline.
Naratriptan
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Naratriptan.
Nefazodone
The metabolism of Nortriptyline can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Nortriptyline can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Nortriptyline can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Nortriptyline can be increased when combined with Nevirapine.
Nialamide
Nialamide may increase the serotonergic activities of Nortriptyline.
Nicardipine
The metabolism of Nortriptyline can be decreased when combined with Nicardipine.
Nicorandil
Nortriptyline may increase the hypotensive activities of Nicorandil.
Nilotinib
Nortriptyline may increase the QTc-prolonging activities of Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Nortriptyline.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Nortriptyline.
Norepinephrine
Nortriptyline may decrease the antihypertensive activities of Norepinephrine.
Norflurane
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Normethadone.
O-PHENANTHROLINE
The serum concentration of Nortriptyline can be increased when it is combined with 1,10-Phenanthroline.
Ofloxacin
Nortriptyline may increase the QTc-prolonging activities of Ofloxacin.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Nortriptyline.
Olaparib
The metabolism of Nortriptyline can be decreased when combined with Olaparib.
Olodaterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Olodaterol.
Olopatadine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Olopatadine.
Omeprazole
The metabolism of Nortriptyline can be decreased when combined with Omeprazole.
Ondansetron
Nortriptyline may increase the QTc-prolonging activities of Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Opium.
Orphenadrine
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Nortriptyline can be increased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Nortriptyline.
Oxprenolol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Nortriptyline.
Oxymetazoline
Nortriptyline may decrease the antihypertensive activities of Oxymetazoline.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Nortriptyline.
p-Hydroxyamphetamine
Nortriptyline may increase the stimulatory activities of Hydroxyamphetamine.
Palbociclib
The serum concentration of Nortriptyline can be increased when it is combined with Palbociclib.
Paliperidone
Nortriptyline may decrease the antihypertensive activities of Paliperidone.
Palonosetron
Palonosetron may increase the serotonergic activities of Nortriptyline.
Panobinostat
The serum concentration of Nortriptyline can be increased when it is combined with Panobinostat.
Pantoprazole
The metabolism of Nortriptyline can be decreased when combined with Pantoprazole.
Paraldehyde
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Nortriptyline.
Pargyline
Pargyline may increase the serotonergic activities of Nortriptyline.
Paroxetine
The risk or severity of adverse effects can be increased when Paroxetine is combined with Nortriptyline.
Pazopanib
Nortriptyline may increase the QTc-prolonging activities of Pazopanib.
Peginterferon Alfa-2b
The serum concentration of Nortriptyline can be decreased when it is combined with Peginterferon alfa-2b.
Pentamidine
Nortriptyline may increase the QTc-prolonging activities of Pentamidine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Nortriptyline.
Pentobarbital
The metabolism of Nortriptyline can be increased when combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Perazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Perazine.
Perflutren
Nortriptyline may increase the QTc-prolonging activities of Perflutren.
Pergolide
Nortriptyline may decrease the antihypertensive activities of Pergolide.
Periciazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Propericiazine.
Perindopril
The serum concentration of Nortriptyline can be increased when it is combined with Perindopril.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Nortriptyline.
Phenelzine
Phenelzine may increase the serotonergic activities of Nortriptyline.
Phenindione
Nortriptyline may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Nortriptyline can be increased when combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Phenoxyethanol.
Phenprocoumon
Nortriptyline may increase the anticoagulant activities of Phenprocoumon.
Phentermine
Nortriptyline may increase the stimulatory activities of Phentermine.
PHENTERMINE RESIN
Nortriptyline may increase the stimulatory activities of Phentermine.
Phenylephrine
Nortriptyline may increase the vasopressor activities of Phenylephrine.
Phenylpropanolamine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Phenylpropanolamine.
Phenytoin
The metabolism of Nortriptyline can be increased when combined with Phenytoin.
Pimozide
Nortriptyline may increase the QTc-prolonging activities of Pimozide.
Pipamperone
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Pipotiazine.
Pirbuterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Pirbuterol.
Pirinitramide
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Pomalidomide.
Posaconazole
The metabolism of Nortriptyline can be decreased when combined with Posaconazole.
Pramipexole
Nortriptyline may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Nortriptyline can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Prilocaine.
Primaquine
Nortriptyline may increase the QTc-prolonging activities of Primaquine.
Primidone
The metabolism of Nortriptyline can be increased when combined with Primidone.
Procainamide
Nortriptyline may increase the QTc-prolonging activities of Procainamide.
Procaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Procaine.
Procarbazine
Procarbazine may increase the serotonergic activities of Nortriptyline.
Procaterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Procaterol.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Nortriptyline.
Promazine
The metabolism of Nortriptyline can be decreased when combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Promethazine.
Propafenone
Nortriptyline may increase the QTc-prolonging activities of Propafenone.
Proparacaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Nortriptyline.
Propoxyphene
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Dextropropoxyphene.
Prothipendyl
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Prothipendyl.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Nortriptyline.
Pseudoephedrine
Nortriptyline may decrease the antihypertensive activities of Pseudoephedrine.
Pyrimethamine
The metabolism of Nortriptyline can be decreased when combined with Pyrimethamine.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Nortriptyline.
Quetiapine
Nortriptyline may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Nortriptyline may increase the QTc-prolonging activities of Quetiapine.
Quinapril
The serum concentration of Nortriptyline can be increased when it is combined with Quinapril.
Quinidine
Nortriptyline may increase the QTc-prolonging activities of Quinidine.
Quinine
Nortriptyline may increase the QTc-prolonging activities of Quinine.
Racecadotril
The serum concentration of Nortriptyline can be increased when it is combined with Racecadotril.
Ramelteon
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ramelteon.
Ramipril
The serum concentration of Nortriptyline can be increased when it is combined with Ramipril.
Ranolazine
The metabolism of Nortriptyline can be decreased when combined with Ranolazine.
Rasagiline
Rasagiline may increase the serotonergic activities of Nortriptyline.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nortriptyline.
Remoxipride
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Nortriptyline.
Rifabutin
The metabolism of Nortriptyline can be increased when combined with Rifabutin.
Rifampin
The metabolism of Nortriptyline can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Nortriptyline can be increased when combined with Rifapentine.
Risperidone
Nortriptyline may decrease the antihypertensive activities of Risperidone.
Ritodrine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ritodrine.
Ritonavir
The metabolism of Nortriptyline can be decreased when combined with Ritonavir.
Rivaroxaban
The serum concentration of Nortriptyline can be increased when it is combined with Rivaroxaban.
Rizatriptan
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Rizatriptan.
Rolapitant
The metabolism of Nortriptyline can be decreased when combined with Rolapitant.
Ropinirole
Nortriptyline may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ropivacaine.
Rotigotine
Nortriptyline may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Nortriptyline can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Nortriptyline.
Salmeterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salmeterol.
Saquinavir
The metabolism of Nortriptyline can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Nortriptyline can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Sarilumab.
Saxagliptin
The serum concentration of Nortriptyline can be increased when it is combined with Saxagliptin.
Saxagliptin Anhydrous
The serum concentration of Nortriptyline can be increased when it is combined with Saxagliptin.
Scopolamine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Scopolamine.
Secobarbital
The metabolism of Nortriptyline can be increased when combined with Secobarbital.
Selegiline
Selegiline may increase the serotonergic activities of Nortriptyline.
Sertindole
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Sertraline is combined with Nortriptyline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Nortriptyline.
Sildenafil
The metabolism of Nortriptyline can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Nortriptyline can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Nortriptyline can be increased when it is combined with Simeprevir.
Sitagliptin
The serum concentration of Nortriptyline can be increased when it is combined with Sitagliptin.
Sitagliptin Phosphate
The serum concentration of Nortriptyline can be increased when it is combined with Sitagliptin.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Sodium Phosphate
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Sodium phosphate.
Sodium Phosphate, Monobasic
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Sodium phosphate.
Sorafenib
The metabolism of Nortriptyline can be decreased when combined with Sorafenib.
Sotalol
Nortriptyline may increase the QTc-prolonging activities of Sotalol.
Spirapril
The serum concentration of Nortriptyline can be increased when it is combined with Spirapril.
ST. JOHN'S WORT EXTRACT
The metabolism of Nortriptyline can be increased when combined with St. John's Wort.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Nortriptyline.
Sulfadiazine
The metabolism of Nortriptyline can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Nortriptyline can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Nortriptyline can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Sumatriptan.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Sumatriptan.
Suvorexant
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Tasimelteon
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Tasimelteon.
Tedizolid
Tedizolid Phosphate may increase the serotonergic activities of Nortriptyline.
Tedizolid Phosphate
Tedizolid Phosphate may increase the serotonergic activities of Nortriptyline.
Telaprevir
The metabolism of Nortriptyline can be decreased when combined with Telaprevir.
Telavancin
Nortriptyline may increase the QTc-prolonging activities of Telavancin.
Telithromycin
The metabolism of Nortriptyline can be decreased when combined with Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Nortriptyline.
Tenofovir Disoproxil
The metabolism of Nortriptyline can be decreased when combined with Tenofovir disoproxil.
Terbinafine
The metabolism of Nortriptyline can be decreased when combined with Terbinafine.
Terbutaline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.
Terbutaline Sulfate
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.
Teriflunomide
The serum concentration of Nortriptyline can be decreased when it is combined with Teriflunomide.
Tetrabenazine
Nortriptyline may increase the QTc-prolonging activities of Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Thalidomide
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theophylline
The metabolism of Nortriptyline can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Nortriptyline can be decreased when combined with Theophylline.
Thiamylal
The metabolism of Nortriptyline can be increased when combined with Thiamylal.
Thiopental
The metabolism of Nortriptyline can be increased when combined with Thiopental.
Thiopental Sodium
The metabolism of Nortriptyline can be increased when combined with Thiopental.
Thioproperazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Thioproperazine.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Nortriptyline.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Nortriptyline.
Thyroid, Porcine
Thyroid, porcine may increase the arrhythmogenic activities of Nortriptyline.
Tiagabine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Tiapride.
Ticagrelor
The metabolism of Nortriptyline can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Nortriptyline can be decreased when combined with Ticlopidine.
Tipranavir
The metabolism of Nortriptyline can be decreased when combined with Tipranavir.
Tizanidine
Nortriptyline may decrease the antihypertensive activities of Tizanidine.
Tocilizumab
The serum concentration of Nortriptyline can be decreased when it is combined with Tocilizumab.
Tolbutamide
The metabolism of Nortriptyline can be decreased when combined with Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Nortriptyline.
Toloxatone
Toloxatone may increase the serotonergic activities of Nortriptyline.
Topiramate
The metabolism of Nortriptyline can be decreased when combined with Topiramate.
Toremifene
Nortriptyline may increase the QTc-prolonging activities of Toremifene.
Tramadol
Nortriptyline may increase the neuroexcitatory activities of Tramadol.
Trandolapril
The serum concentration of Nortriptyline can be increased when it is combined with Trandolapril.
Tranylcypromine
Tranylcypromine may increase the serotonergic activities of Nortriptyline.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Nortriptyline.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Nortriptyline.
Triazulenone
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Nortriptyline.
Triflupromazine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Triflupromazine.
Trimethoprim
The metabolism of Nortriptyline can be decreased when combined with Trimethoprim.
Trimipramine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Nortriptyline.
Tropisetron
Tropisetron may increase the serotonergic activities of Nortriptyline.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Nortriptyline.
Urethane
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ethyl carbamate.
Valproate
The serum concentration of Nortriptyline can be increased when it is combined with Valproic Acid.
Valproic Acid
The serum concentration of Nortriptyline can be increased when it is combined with Valproic Acid.
Valsartan
The metabolism of Nortriptyline can be decreased when combined with Valsartan.
Vandetanib
Nortriptyline may increase the QTc-prolonging activities of Vandetanib.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Nortriptyline.
Venlafaxine
The risk or severity of adverse effects can be increased when Venlafaxine is combined with Nortriptyline.
Verapamil
The metabolism of Nortriptyline can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Vigabatrin.
Vilanterol
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Vilanterol.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Nortriptyline.
Vildagliptin
The serum concentration of Nortriptyline can be increased when it is combined with Vildagliptin.
Voriconazole
The metabolism of Nortriptyline can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Nortriptyline.
Warfarin
Nortriptyline may increase the anticoagulant activities of Warfarin.
Xylometazoline
Nortriptyline may decrease the antihypertensive activities of Xylometazoline.
Yohimbine
The serum concentration of Yohimbine can be increased when it is combined with Nortriptyline.
Zafirlukast
The metabolism of Nortriptyline can be decreased when combined with Zafirlukast.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Nortriptyline.
Ziconotide
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ziconotide.
Ziprasidone
Nortriptyline may increase the QTc-prolonging activities of Ziprasidone.
Zofenopril
The serum concentration of Nortriptyline can be increased when it is combined with Zofenopril.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Nortriptyline.
Zolpidem
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Nortriptyline.
Zotepine
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Zotepine.
Zuclopenthixol
Nortriptyline may increase the QTc-prolonging activities of Zuclopenthixol.
